Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

1. P1291

   Comparative in vitro activity of ceftazidime-avibactam against Gram-negative pathogens from hospital-acquired lower respiratory tract infections in the European union: 2013 INFORM surveillance programme

   Doug Biedenbach, Schaumburg, United States

   Lob, Sibylle; Badal, Robert *; Hackel, Meredith; Reiszner, Edina; Stone, Gregory;

   28 April 2015

   Session: New data on new cephalosporin/beta-lactamase inhibitor combinations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2015
   Copenhagen, Denmark
   Poster presentation

   Bacterial Susceptibility & Resistance

2. P1292

   Antimicrobial resistance patterns of ceftazidime-avibactam and comparators against intra-abdominal Gram-negative pathogens from Europe: international network for optimal resistance monitoring (INFORM) global surveillance study 2013

   Doug Biedenbach, Schaumburg, United States

   Lob, Sibylle; Badal, Robert *; Hackel, Meredith; DeJonge, Boudewijn; Stone, Gregory;

   28 April 2015

   Session: New data on new cephalosporin/beta-lactamase inhibitor combinations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2015
   Copenhagen, Denmark
   Poster presentation

   Bacterial Susceptibility & Resistance

3. P1293

   Activity of ceftazidime-avibactam and comparators against carbapenemase-producing Enterobacteriaceae isolated in sampled countries of the European Union: 2013 INFORM surveillance programme

   Doug Biedenbach, Schaumburg, United States

   Biedenbach, Douglas *; deJonge, Boudewijn; Nichols, Wright W.; Sahm, Daniel;

   28 April 2015

   Session: New data on new cephalosporin/beta-lactamase inhibitor combinations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2015
   Copenhagen, Denmark
   Poster presentation

   Bacterial Susceptibility & Resistance

4. P1294

   In vitro activity of ceftazidime-avibactam and other agents against Pseudomonas aeruginosa isolated in selected countries of the European union in 2013

   Doug Biedenbach, Schaumburg, United States

   Biedenbach, Douglas *; deJong, Boudewijn; Nichols, Wright W.; Sahm, Daniel;

   28 April 2015

   Session: New data on new cephalosporin/beta-lactamase inhibitor combinations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2015
   Copenhagen, Denmark
   Poster presentation

   Bacterial Susceptibility & Resistance

5. P1053

   Current status of carbapenem-resistant Enterobacteriaceae (CRE) in Europe

   Doug Biedenbach, Schaumburg, United States

   Kazmierczak, Krystyna *; Hackel, Meredith; Estabrook, Mark; Li, Henry; Biedenbach, Douglas; Johnson, Brian; Leister-Tebbe, Heidi;

   27 April 2015

   Session: Recent epidemiological data on carbapenem-resistant Enterobacteriaceae

   Relevance:

    

   100%

    

   

   Event: ECCMID 2015
   Copenhagen, Denmark
   Poster presentation

   Bacterial Susceptibility & Resistance

6. P0967

   Antimicrobial susceptibility profiles of key intra-abdominal (IAI) bacterial isolates from western Europe

   Doug Biedenbach, Schaumburg, United States

   Hackel, Meredith *; Biedenbach, Douglas; Leister-Tebbe, Heidi;

   27 April 2015

   Session: More and more third generation cephalosporin-resistent enteric bacteria everywhere?

   Relevance:

    

   100%

    

   

   Event: ECCMID 2015
   Copenhagen, Denmark
   Poster presentation

   Bacterial Susceptibility & Resistance

7. P0961

   Molecular profiling of beta-lactam-resistant Enterobacteriaceae collected as part of the Tigecycline European Surveillance Trial (TEST) in 2012-2013

   Doug Biedenbach, Schaumburg, United States

   Kazmierczak, Krystyna *; Hackel, Meredith; Li, Henry; Estabrook, Mark; Biedenbach, Douglas; Johnson, Brian; Leister-Tebbe, Heidi;

   27 April 2015

   Session: More and more third generation cephalosporin-resistent enteric bacteria everywhere?

   Relevance:

    

   100%

    

   

   Event: ECCMID 2015
   Copenhagen, Denmark
   Poster presentation

   Bacterial Susceptibility & Resistance

8. P1778

   Tigecycline activity against enteric pathogens resistant to amikacin as determined from TEST program analysis over ten years - TEST 2013

   Doug Biedenbach, Schaumburg, United States

   Bouchillon, S.(1)*; Biedenbach, D.(1); Hackel, M.(1); Badal, R.(1); Hawser, S.(2); Leister-Tebbe, H.(3);

   13 May 2014

   Session: MDR Gram-negatives - clinical observations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

9. P1781

   Activity of ceftazidime-avibactam and comparators versus characterised ESBL-positive Gram-negative bacteria isolated in the European region: 2012 programme

   Doug Biedenbach, Schaumburg, United States

   Kazmierczak, K.(1)*; Hickman, S.(1); Hackel, M.(1); Badal, R.(1); Biedenbach, D.(1); Morrissey, I.(2); Bouchillon, S.(1); Stone, G.(3);

   13 May 2014

   Session: MDR Gram-negatives - clinical observations

   Relevance:

    

   100%

    

   

   Event: ECCMID 2014
   Barcelona, Spain
   Poster presentation

   Bacterial Susceptibility & Resistance

10. P1782

    Activity of ceftazidime-avibactam versus Pseudomonas aeruginosa, including multiple-drug resistant isolates in Europe - the 2012 INFORM programme

    Doug Biedenbach, Schaumburg, United States

    Bouchillon, S.(1)*; Hoban, D.(1); Hackel, M.(1); Badal, R.(1); Morrissey, I.(2); Biedenbach, D.(1); Nichols, W.(3);

    13 May 2014

    Session: MDR Gram-negatives - clinical observations

    Relevance:

     

    100%

     

    

    Event: ECCMID 2014
    Barcelona, Spain
    Poster presentation

    Bacterial Susceptibility & Resistance